Home/Filings/4/0001766524-25-000004
4//SEC Filing

Koenig Sheldon L. 4

Accession 0001766524-25-000004

CIK 0001434868other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:06 PM ET

Size

5.0 KB

Accession

0001766524-25-000004

Insider Transaction Report

Form 4
Period: 2025-09-17
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2025-09-17$2.79/sh28,427$79,2541,518,831 total
Footnotes (2)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
  • [F2]Includes 5,770 shares recently acquired in Esperion's Employee Stock Purchase Plan.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001766524

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:06 PM ET
Size
5.0 KB